Search

everythinglearnresearchcommunity

for

Search:↓

Testosterone therapy is generally safe for transmen, improves sexual function, and has manageable health risks with proper monitoring.

The document concludes that new treatments are needed to better manage acne and reduce side effects related to current therapies.

Testosterone therapy seems safe and effective for transgender men with proper care, but more long-term research is needed.

COVID-19 and hypopituitarism (reduced pituitary gland function) are linked, with the latter's related health issues potentially worsening COVID-19 outcomes, and COVID-19 possibly increasing risk for pituitary complications.

The document concludes that managing PCOS involves treating symptoms and reducing long-term metabolic risks, with lifestyle changes being important.

Hormone therapy may increase migraines in transgender women and decrease them in transgender men; more research is needed on migraine management in transgender individuals.

The document concludes that combination therapy is most effective for treating excessive hair growth in women with idiopathic hirsutism, and more research is needed to understand the condition.

Women with PCOS have a higher risk of heart disease.

Androgen therapy can help with symptoms like low libido in women, but more research is needed to understand its long-term safety and effects on health.

Testosterone therapy seems safe for postmenopausal women for a few years, but more research is needed for long-term effects.

The document concludes with guidance for doctors on diagnosing and treating hirsutism effectively and safely.

70.7% of patients had long-COVID symptoms like fatigue, cough, and brain fog three months after recovery.

Better patient selection for gastric cancer surgery can reduce complications and improve survival.

People with Alopecia Areata have more herpes simplex infections but similar rates of cancer, blood clots, and heart disease compared to those without it.

Alopecia treatments like 5α-reductase inhibitors and spironolactone are safe for breast cancer patients and high-risk women.

A girl with lupus and trisomy X has a higher risk of bone problems like avascular necrosis and osteoporosis.

Non-medical steroid use in gym-goers is risky and needs better prevention and care strategies.

Athletic trainers should understand and support the medical needs of transgender and gender-diverse patients.

Hormone therapy for prostate cancer can increase heart risks, especially in men with heart conditions.

Alopecia areata patients don't have increased atherosclerosis risk, but may have higher cardiovascular risk due to smoking, blood sugar, and blood pressure.

Transgender patients in critical care need better-trained medical staff and specific guidelines.

Androgen use may increase the risk of stroke, but more research is needed.

Avacopan may cause unexpected side effects, so early monitoring is important.

Hair loss may indicate higher risk of heart disease.

Bridging anticoagulation may raise post-surgery bleeding risks.

Hormonal therapy for transgender individuals carries health risks but is a personal choice.

Reproductive factors can increase hypertension risk and affect cardiovascular health.

Genetics influence opioid addiction risk, diet affects COVID-19 severity, Aerva lanata may harm kidneys, some plants fight fungi and cancer, and nursing students need better contraceptive knowledge.

Finasteride may increase stroke risk in people with clotting tendencies.